Estimaciones de analistas de Wall Street para Foghorn Therapeutics Inc. (FHTX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-04 | $-0.22 | ||
| 2026-08-06 | $-0.10 | $-0.24 | +59.2% |
| 2026-05-07 | $-0.29 | $-0.28 | -3.6% |
| 2026-03-11 | $-0.34 | $-0.28 | -21.4% |
| 2025-11-05 | $-0.25 | $-0.31 | +19.4% |
| 2025-08-05 | $-0.28 | $-0.31 | +9.7% |
| 2025-05-14 | $-0.30 | $-0.30 | +0.0% |
| 2025-03-06 | $-0.30 | $-0.43 | +30.2% |
Ratios de valoración
| Precio / Valor contable | -3.63 |
| EV / EBITDA | -3.75 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $430000 | $1.3M | $19.2M | $34.2M | $22.6M | $30.9M |
| Coste de Ventas | $379000 | $1.8M | $57.7M | 0 | 0 | 0 | 0 | $3.3M |
| Beneficio Bruto | -$379000 | -$1.8M | -$57.3M | $1.3M | $19.2M | $34.2M | $22.6M | $27.6M |
| I+D | $21.2M | $44.4M | $57.7M | $80.3M | $105.6M | $109.7M | $94.5M | $85.5M |
| Generales y Administrativos | $4.8M | $4.9M | $11.2M | $21.7M | $30.7M | $32.4M | $28.4M | $27.6M |
| Gastos Operativos | $26.0M | $49.3M | $11.2M | $102.1M | $136.4M | $142.1M | $125.3M | $109.7M |
| Beneficio Operativo | -$26.0M | -$51.1M | -$68.5M | -$100.7M | -$117.1M | -$107.9M | -$102.7M | -$82.1M |
| EBITDA | -$25.6M | -$48.8M | -$67.2M | -$96.2M | -$105.6M | -$90.7M | -$97.2M | -$71.0M |
| Gastos por Intereses | $371000 | $540000 | $979000 | $1.9M | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$26.3M | -$51.1M | -$68.8M | -$101.3M | -$108.9M | -$94.2M | -$86.6M | -$74.3M |
| Impuestos | $83000 | 0 | 0 | 0 | 0 | $4.2M | 0 | 0 |
| Beneficio Neto | -$26.3M | -$51.1M | -$68.8M | -$101.3M | -$108.9M | -$98.4M | -$86.6M | -$74.3M |
| BPA | $-1.34 | $-1.40 | $-1.90 | $-2.78 | $-2.62 | $-2.34 | $-1.58 | $-1.18 |
| BPA Diluido | $-1.34 | $-1.40 | $-1.90 | $-2.78 | $-2.62 | $-2.34 | $-1.58 | $-1.18 |
| Acciones en Circulación (Diluidas) | $19.6M | $36.8M | $36.8M | $37.2M | $41.6M | $42.0M | $54.9M | $63.0M |
Precio
| Precio | $4.17 |
| Capitalización | $245M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ARCT · ASMB · ENTA · HUMA · IMRX · PYXS · SGMT
Explorar sector: Healthcare · Biotechnology
Más secciones de FHTX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones